Juvederm XC received FDA clearance last week, as pharmaceutical co. Allergan Inc cited positive results from clinical trials where over 90 percent of the 36 participants reported a more comfortable procedure with the new formulation.
Juvederm XC is the latest addition in the wave of fillers released in the U.S. that contain lidocaine, an anesthetic said to numb the treatment area within seconds. The first wrinkle filler of this kind, Prevelle Silk, was approved in 2008. However, physicians weren’t so eager to jump on the lidocaine-bandwagon 2 years ago. Continue reading